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Abstract
Postweaning diarrhoea (PWD) is a significant enteric disease causing considerable economic
losses for the pig industry. Among several aetiological risk factors, enterotoxigenic Escherichia coli
(ETEC) is considered to be a major cause. After being routinely used for several decades to control
bacterial disease outbreaks in piglets, the use of antibiotics at subtherapeutic concentrations has
been banned in the European Union because of the increasing prevalence of resistance to antibiotics
in pigs. The removal of in-feed antibiotics from piglet diets has negative economic consequences as
it dramatically increases the rate of morbidity and mortality due to ETEC as well as the use of
antibiotics for therapeutic purposes. Other than subtherapeutic antibiotics, zinc oxide (ZnO) has
been reported to ameliorate and/or prevent the development of PWD in piglets, but its excretion
may have negative impacts on the environment. Thus, other alternatives that can control ETEC
infections in piglets postweaning will be of great advantage. A number of nutritional strategies have
been proposed as alternative means of preventing ETEC infections, of which feeding dairy-based
products to piglets could be one of such strategies. It is apparent that colostrum, milk and milk
fractions such as whey and casein contain several biologically active compounds with anti-microbial
and immunomodulatory properties. Recently, these dairy products and their isolated compounds
such as lactoferrin and oligosaccharides have been employed as anti-infective agents against ETEC
infections in piglets postweaning. The dairy by-products (e.g. whey or whey permeate) may also be
fermented to further improve the anti-infective potential of the products. Overall, the anti-infective
activities of dairy-based products against ETEC could be attributed to the improvement of
the intestinal barrier functions, microbial ecosystem and immunity of the piglets.
Keywords: Dairy-based product, Anti-microbial, Immunomodulation, Anti-infective, Enterotoxigenic
Escherichia coli, Postweaning diarrhoea, Piglet
Review Methodology: We conducted a literature search with focus on ETEC-induced PWD and the preventive effect of dairy-based
nutrition using the following criteria: (1) peer-reviewed journal articles in English were included; (2) articles or chapters in an edited book
were selectively included; (3) grey literature such as Ph.D. theses was selectively included; (4) published reports from the official
organization such as The Danish Integrated Anti-microbial Resistance Monitoring and Research Programme (DANMAP) and European
Food Safety Authority (EFSA) were selectively included; (5) in vitro and in vivo investigations on pigs were included; (6) in vitro and
in vivo studies on humans and rodents were selectively included, provided that the aims were to investigate the cell/host–pathogen
interactions and/or enteric infections; (7) in vivo studies with the aim to investigate the gastric infections were excluded.
Introduction
Postweaning diarrhoea (PWD) has been reported to be
the most common enteric disease with a great economic
impact on the pig industry [1]. Bacteria, viruses and
parasites are among the infectious agents associated with
diarrhoea [2]. In the pig industry, much attention has been
focused on enterotoxigenic Escherichia coli (ETEC), as it is
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estimated that half of piglet mortality due to diarrhoea
is attributable to ETEC [3]. A subtherapeutic use of
antibiotics has been routinely practiced in swine industry
for decades to deal with ETEC infections postweaning.
However, this practice has been banned by the European
Union since 1 January 2006 because of the risk of devel-
opment of anti-microbial resistance and transference
of antibiotic resistance genes from animal to human
microbiota [1]. Because of this ban, a number of alter-
natives based on the nutritional practices have been
proposed to control the increased rate of mortality and
morbidity [4].
Apart from inorganic zinc that may contaminate
the environment [1], some feeds or feed ingredients have
been suggested to possess immunomodulatory and anti-
microbial properties, and thus can help to protect the
piglets against ETEC infections [5]. Of these ingredients,
dairy-based products have gained increasing interest as a
potential nutritional tool to prevent piglets from devel-
oping diarrhoea due to ETEC [6–9]. Freeze-dried (defat-
ted) bovine colostrum (BC), liquid whey, spray dried
whey isolate (whey meal), whey protein concentrate,
whey permeate and spray dried calcium caseinate are
among the milk-derived products that have been studied
to improve the intestinal health of pigs. Likewise, several
biologically active compounds such as lactoferrin, lyso-
zyme, lactoperoxidase, immunoglobulin (Ig), phospholipid,
oligosaccharides and glycoconjugates have been isolated
from milk or milk fractions, and these components may
have therapeutic properties in prevention and inhibition
of ETEC infections [10–16]. The purpose of this review
is to update the current knowledge pertaining to the
potential preventive effects of dairy-based products on
ETEC infections in piglets postweaning.
ETEC Infections in Piglets
Escherichia coli are part of the normal microbiota in
the gastrointestinal tract and are found in both healthy
and diseased pigs. Although most of E. coli are not
pathogenic, some of them encode genes that can impart
virulence [17]. To date, eight E. coli pathovars have been
characterized, and each uses several virulence factors to
subvert host cellular functions and to potentiate its viru-
lence. Six out of the eight pathovars have been classified
as diarrhoeagenic, including enteropathogenic E. coli,
enterohaemorrhagic E. coli, enterotoxigenic E. coli (ETEC),
enteroinvasive E. coli, enteroaggregative E. coli and diffu-
sely adherent E. coli [2]. Among these diarrhoeagenic
E. coli, ETEC is the most common cause of diarrhoea in
newborn and weaned piglets [4, 17].
ETEC strain expressing F4 fimbriae are highly prevalent
in pigs. Currently, three antigenic variants of the F4
fimbriae have been identified in porcine ETEC strains,
i.e. F4ab, F4ac and F4ad [18]. Of these variants, F4ac are
the most important variants of ETEC F4 [4, 18]. ETEC F18
is another common strain of ETEC isolated from piglets
suffering from diarrhoea. So far, two antigenic variants
of F18 can be characterized, i.e. F18ab and F18ac. To elicit
diarrhoea in piglets, ETEC F4 or F18 must first adhere
to specific porcine enterocyte receptors for the F4 or
F18 fimbriae, respectively [1, 4]. This adhesion facilitates
colonization of the distal jejunum and proximal ileum
mucosa by ETEC and enables them to transmit enter-
otoxins leading to diarrhoea [17]. The detailed patho-
genesis of ETEC infections and the mechanisms by which
enterotoxins (produced by ETEC) induce diarrhoea in
piglets have been extensively reviewed elsewhere and are
not discussed further here.
Antibiotics and Zinc to Control ETEC infections
in Piglets
In the past, antibiotics were routinely used to control
enteric bacterial infections, such as diarrhoea, in piglets
after weaning. The risk of developing anti-microbial resis-
tance and transference of antibiotic resistance genes from
pig to human microbiota has led the European Union to
ban the application of subtherapeutic use of antibiotics in
the swine industry since 1 January 2006. Consequences
of this ban include a dramatic increase in the prevalence
of PWD, an increase in the postweaning mortality rate
and an increased use of therapeutic antibiotics [19].
In Denmark, it was reported that therapeutic use of
antibiotics in pigs increased by 25% compared with the
pre-ban levels [20], and during the period 2001–2009 the
anti-microbial consumption in the pig production
increased gradually by 36% [21].
Apart from the long-term effect of antibiotics on the
development of antibiotic resistance, the subtherapeutic
use of antibiotics has been reported to have a short-term
impact on the composition of microbiota in the intestine
[22, 23]. Antibiotics may, concomitant with the reduction
in pathogens, decrease the number of Lactobacillus, species
which are generally considered to be beneficial to the
host [24]. Both the reduced species diversity and the
total number of bacteria in the intestine of pigs have
also been attributed to the treatment with antibiotics
[24, 25]. It has been widely accepted that an altered
composition and diversity of the intestinal microbiota
may affect the intestinal immune system and intestinal
epithelial barrier functions of the host. In this regard,
the use of antibiotics may thereby affect host immune
defence mechanisms [23]. For example, Hill et al. [26]
reported that antibiotic treatment reduced (10-fold) the
amount of intestinal bacteria and changed the intestinal
microbial communities in the gut of murine model.
Concurrently, this antibiotic administration caused sig-
nificant alterations in the expression of proinflammatory
cytokines by CD4+ T lymphocytes in the gut-associated
lymphoid tissue. Overall, it should be noted that both
oral and intravenously administered antibiotics may
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have implications on the intestinal microbiota com-
position and the immune functions of the host [23]. In
addition, the alterations in the intestinal microbiota per-
sist for a long period after termination of the antibiotics
administration [22].
Feeding supplemental zinc (zinc oxide, ZnO) to weaned
pigs at pharmacological levels up to 2500 mg/kg, which is
allowed in Denmark and Belgium, have been reported
to ameliorate and/or prevent the development of PWD
[4, 27], and hence could be a substitute for in-feed
antibiotics. The mechanism by which zinc exert the PWD-
reducing effect has not yet been fully elucidated, but it
may be due to the anti-microbial and immune-enhancing
properties of zinc (Table 1). According to Højberg et al.
[27] the effect of zinc resembles the working mechanism
suggested for some in-feed antibiotics, i.e. the suppression
of gram positive commensals (lactic acid bacteria; LAB)
rather than potentially pathogenic Gram-negative organ-
isms (coliforms). This condition may therefore have long-
term negative consequences on the immune functions of
piglets [26]. Janczyk et al. [28] reported that feeding
supplemental zinc (2500 mg/kg) immediately after weaning
could positively affect the immune responses of piglets
infected with Salmonella typhimurium, but for a short
period only. After 2 weeks, all positive effects disappeared
and rather negative effects, such as lower T-cell fre-
quencies, occurred. Apart from the potential protection
of zinc against ETEC in pigs, environmental considerations
should be taken into account when using zinc at high
levels, as this leads to heavy metal contamination of the
soil [4]. Taken together, zinc is not feasible alternatives to
in-feed antibiotics in piglets.
Dairy Products to Control ETEC infections
in Piglets
The compromised immune functions and subsequent
increased colonization of the porcine small intestine by
ETEC during the weaning transition period have been
proposed to contribute to the outbreaks of PWD [1].
Considering that nutrition and diet play substantial roles
in the composition of intestinal microbiota and immune
status of the host [23], various nutritional interventions
(Table 1) have been investigated as possible tools to pre-
vent the disruption of gut microbial ecosystem and impair-
ment of the immune system, hence preventing the
development of PWD. Dietary intervention studies have
especially been intensified following the ban of sub-
therapeutic use of antibiotics in pig productions, because
of the need for alternative strategies. A number of dietary
components and/or feeding regimes have been suggested
to provide factors that beneficially influence the intestinal
microbiota, the immune system as well as the epithelial
barrier function, and thus the antigen exposure [5, 29]. In
this review, some basic relationships between nutritional
interventions and intestinal health of piglets postweaning
will be highlighted, giving dairy-based products the major
focus.
Mammalian milk including bovine milk contains a wide
variety of factors that contribute to the protection of
the newborn with immature immune defence system
against infections [30]. In addition to the anti-microbial
and immune components, milk contains several growth
factors (e.g. beta cellulin, epidermal growth factor, insulin-
like growth factor, transforming growth factor [TGF],
etc.) which are essential for the general development
of the young mammals [13, 30]. There is now a lot of
evidence suggesting that bioactive components of bovine
milk can act as anti-microbial and immunomodulatory
agents in ruminant as well as in non-ruminant species
[31]. Therefore, the use of dairy-based products may
be expected to preserve a healthy intestine and prevent
ETEC-induced PWD in piglets.
The detailed mechanisms through which the dairy-
based products protect pigs from ETEC infections are
largely unknown, but in general these mechanisms may
lead to an improvement of the intestinal microbial eco-
system and immune functions of the pigs [7, 32–34]. In
addition, the dairy products may preserve the intestinal
integrity and prevent the intestinal barrier (mucosa)
from disruption by controlling the excessive expression
of proinflammatory mediators in response to invading
pathogens [34–37].
Preventive potential of bovine colostrum on
ETEC infections in piglets
Colostrum is milk secreted by mammary glands during
the first few days postpartum. In the case of the cow,
colostrum is defined as the milk secreted for the first
4 days postpartum [38]. In addition to its value as a
complete nutrient source for the newborn calf, BC has
gained increasing interest as a source of nutraceuticals for
other mammals including pigs. Colostrum contains various
anti-microbial components, such as Igs, lactoferrin, lyso-
zyme and lactoperoxidase, which could exert both
bacteriostatic and bactericidal activity [13, 35]. It also
contains several immune components which play impor-
tant roles in host defence against infections, including Igs,
cytokines and lactoferrin. Of these immune components,
Igs appear to be the most abundant immune components
as they represent 70–80% of the total protein content in
colostrum. Three isotypes of Igs are present in colostrum,
i.e. IgG, IgA and IgM. The most abundant Ig in colostrum
is IgG of which 95% belong to the subclass IgG1 and 5%
to the IgG2 [13]. It is known that the content of Igs in
colostrum varies among animal species [39]. Compared
with sow colostrum, BC has lower proportions of IgA and
higher IgM, but the proportion of IgG does not signific-
antly differ between both species (Figure 1). The major
bioactive components in BC are presented in Table 2.
It should be noted that the mentioned-bioactive
http://www.cabi.org/cabreviews
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components in colostrum are also present in milk, but in
much lower concentrations (e.g. typically 1 : 100 to
1 : 1000 of what is found in colostrum) [13].
In addition to the content of anti-microbial and immune
factors, BC is a good source of a range of bioactive pep-
tides which act as regulatory compounds and support the
defence system of the host [40]. Colostrum also contains
oligosaccharides and glycoconjugates, which may provide
the host a protection against bacterial pathogens [10].
Several potentially proinflammatory components in BC,
including tumour necrosis factor-a (TNF-a) and inter-
feron- g (IFN-g) [13, 30], makes BC capable of augmenting
the immune responses leading to rapid clearance and/or
less colonization of the intestine by pathogens. However,
it should be noted that excessive expression of these
proinflammatory cytokines in the gut may induce inflam-
mation resulting in diarrhoea in piglets. Fortunately, BC is
also rich in TGF-b, which is able to control inappropriate
inflammatory responses and preserve the epithelial
barrier function after infections [13]. BC is also claimed
to contain anti-oxidative factors, which are beneficial
against the oxidative damage (stress) caused by infections
[38, 41]. The anti-oxidative factors include enzymatic as
well as non-enzymatic anti-oxidants (Table 2).
BC is one of the commercially available co-products
of the dairy industry that has been shown to control
the outbreaks of PWD in piglets [7, 42]. The definite
mechanism through which BC shortens PWD episodes
remains unknown, but a combined action of anti-microbial
and immunomodulatory factors of BC are likely to be
involved [33, 43]. In addition, the potential of BC to lower
the gastric pH and to increase the duodenal lactobacilli:
coliform ratio [32] may balance the intestinal ecosystem,
which in turn may prevent PWD. The potential of BC to
preserve the intestinal integrity by maintaining the villi
height and crypt depth after weaning [13] seems also to
contribute to the reduced PWD. In continuation of the
earlier works, Sugiharto et al. [42] showed that feeding
BC reduced the adherence of ETEC F18 to porcine inte-
stinal tissue ex vivo, and hence may reduce the intestinal
colonization by ETEC and prevent the development of
ETEC-induced diarrhoea. Apart from the preventing
potential of BC on the development of PWD, the dose of
BC included in the diet of pigs is another concern that
should be taken into account. This is most likely ascribed
by the high price of BC in the current market. In their
review, Boudry et al. [13] noticed that most of the cited
authors incorporated 5–10% of BC in the diet of piglets
during their studies. Hence, further studies with less
proportion of BC included in the diet of piglets are of
importance in order to make BC applicable for the
commercial pork production systems.
Preventive potential of whey and whey protein
on ETEC infections in piglets
Whey is a byproduct of cheese-making, which was tra-
ditionally regarded as a waste with little or no commercial
value [44]. Whey is the second most abundant source of
protein in the milk (approximately 20% of the total milk
proteins) after casein. From the nutritional point of view,
whey protein has been regarded to be superior to casein,
in that whey protein is absorbed faster than casein in
humans [45]. Moreover, whey proteins have proportio-
nately more sulphur-containing amino acids (cysteine and
methionine) than casein, contributing to the higher pro-
tein efficiency ratio of whey proteins than of casein [44].
Beyond the nutritional aspect, whey proteins and their
derived-peptides are known to modulate a variety of
immune functions including lymphocyte activation and
proliferation, cytokine secretion, antibody production,
phagocytic activity and granulocyte and NK cell activity
[31, 46]. Besides being responsible for the nutritional
quality of whey proteins, the sulphur-containing
amino acids appear important to the ability of whey
proteins to enhance immune functions via modulation of
the sulphur-containing tripeptide glutathione [44]. Like-
wise, some individual proteins derived from whey, such
as b-lactoglobulin, a-lactalbumin, Igs, lactoferrin and lac-
toperoxidase may contribute to the immunomodulatory
and/or anti-microbial activities of whey or whey proteins
[31, 44, 46]. The major individual proteins derived
from whey and their potential immunomodulatory
and/or anti-microbial activities are summarized in Table 3.
Recently, there has also been a considerable interest
in the non-protein components of whey that may possess
anti-microbial and immunomodulatory properties,
including phospholipid (phosphatidylethanolamine, phos-
phatidylcholine and sphingomyelin are the predominant
fractions), oligosaccharides and glycoconjugates (Table 3).
Most of the studies on anti-microbial and immunomo-
dulatory activities of whey-derived bioactive compounds
have been conducted in vitro with focus on specific
isolated whey components (see references in Table 3).
IgG
IgA
IgM
Pig Cow
Figure 1 Relative distribution of Igs in colostrum (outer
circle) and in milk (inner circle) of the sow and the cow
(adopted from [39]). The overall concentration of total Igs is
higher in colostrum than that in milk, and is relatively higher
in the sow milk than that in the bovine milk (based on the
relative size of the circles).
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However, differences between the results of in vitro and
in vivo studies have often been seen. For example, Sarelli
et al. [11] showed that lactoferrin (purified from cheese
whey) inhibited the growth of E. coli O147 in vitro, but had
no effect on the faecal haemolytic E. coli counts and PWD
in piglets. Therefore, further in vivo studies are needed to
confirm the anti-microbial and immunomodulatory activ-
ities of the bioactive compounds derived from whey at
the whole-animal level. Rivera et al. [47] showed that
lactoferrin inhibited ETEC H10407 growth in a dose-
dependent manner and reduced secretory diarrhoea
caused by cholera toxin in mice. Likewise, Wang et al.
[12] reported that feeding lactoferrin reduced total
viable counts of E. coli and Salmonella, increased the
number of Lactobacillus and Bifidobacterium in the small
intestine and improved the morphology of the small
intestine (increased villus height and lowered crypt depth)
in piglets. This study also revealed that treatment with
lactoferrin was able to reduce the incidence of PWD in
piglets by 66.2% from piglets received control basal diet.
Based on the anti-microbial and immunomodulatory
potential of each single isolated whey components, there
is a potential in combining these components and feeding
them to piglets in order to improve health. This strategy,
however, may not give the expected synergistic effects
as factors such as lactoferrin and lactoperoxidase exhibit
the immunomodulating actions only in their isolated form
[48] and the effects of both compounds are diminished
when they are combined with other milk factors [48, 49].
However, Kobayashi et al. [6] observed that feeding liquid
whey to piglets resulted in larger populations of lacto-
bacilli and bifidobacteria and less population of Clostridium
disporicum in the intestine and they suggested that whey
is useful for promoting the intestinal health of piglets
and preventing PWD. Concomitant with this, a study in
Wistar albino rats by Anbarasu et al. [50] demonstrated
Table 3 Bioactive components in whey
Bioactive compounds Biological activities References
Whey protein:
- b-lactoglobulin Mediates cellular activation in both human and murine immune cells [116]
Enhances the human neutrophil responses to antigen stimulation [117]
Increases cell proliferation and antibody production in murine spleen cell
culture
[118]
Exhibits potential anti-oxidative effects [37]
- a-lactalbumin Inhibits the association of the pathogens (ETEC, S. typhimurium, and
S. flexneri) with intestinal cells
[119]
Activates human neutrophils in response to antigen stimulation [117]
Increases the humoral responses of mice and splenic mitogen responses [119]
Enhances IL-1b production [49]
- Serum albumin Increases antibody production in chickens [120]
Exhibits potential anti-oxidative activity [121]
- Igs Exhibits anti-microbial activity [122]
Provides passive immunity [37, 119]
- Lactoferrin Kills or slows bacterial growth synergistically with other factors present in
mucosal secretion (Igs, complement, lysozime).
[123]
Exerts anti-microbial activity through iron deprivation or damages the
outer membrane of bacteria
[119, 122, 124]
Decreases the binding of cholera toxin (CT) and CT’s B subunit to
GM1-ganglioside on the surface of intestinal cells of mice.
[47]
Stimulates murine lymphocyte proliferation in vitro and Igs production [125]
Potentiates the gut immune system, and enhances and reconstitutes the
peripheral immune system
[119]
Attenuates cytokine production of Th1, but not Th2 cell line [119]
Exhibits potential anti-oxidative effects [37]
- Lactoperoxidase Exhibits anti-microbial functions [37]
Inhibits proliferation and IFN-g production of ovine blood lymphocytes in
response to mitogenic stimulation
[49]
- Phospholipid Exhibits anti-microbial and anti-viral activity in vitro [35]
Inhibits the excessive expression of proinflammatory mediator
expression
[36]
Prevents gastric mucosal damage [35, 110]
Oligosaccharides Stimulate the growth and/or activity of favourable bacteria in the intestine [10]
Inhibit the proliferation of pathogenic gram-negative bacteria in the
intestine
[37]
Provide a means to inhibit pathogen adhesion to the intestinal epithelium [10]
Modulate (induce) the inflammatory immune responses [37]
Glycoconjugates Act as receptor analogues of epithelial cell-surface carbohydrate and can
therefore compete with pathogenic bacteria for attachment sites
[10, 16, 124]
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anti-diarrhoeal action of whey powder against diarrhoea
induced by castor oil. Overall, the potential of whey and
whey components to improve the intestinal ecosystem
and immune functions of the host seems to prevent ETEC
infections in piglets especially during the postweaning
period.
Preventive potential of whey permeate on ETEC
infections in piglets
Whey permeate is produced by removing protein and
other solids from whey resulting in a product with a high
content of lactose (~80% lactose). Because of its lactose
content, whey permeate has been used as a pure-lactose
replacer for weaned piglets to increase their feed intake
and growth performance during the first 2 weeks post-
weaning [51]. It has been reported that provision of lac-
tose was associated with an increase in population of
probiotic species (Lactobacillus johnsonii and Lactobacillus
reuteri) in the intestine of nursery pigs, as lactose may act
as a specific substrate for lactobacilli [52]. Taking these
facts into consideration, the use of whey permeate as a
substitute for the pure-lactose in piglet diet is likely to
improve the intestinal ecosystem and health of the piglets
as well. In the study of Manurung [8], it was shown that
feeding whey permeate at 60 or 120 g/kg reduced the
coliform counts in caecum and colon of piglets after
weaning although the balance of the colonic microbiota
was not affected. As E. coli can utilize lactose as an energy
and carbon source [53], fermentation of whey permeate
to minimize the content of lactose before feeding to
piglets may reduce the amount of substrate for pathogenic
E. coli in the intestine. Consistent with this, we previously
showed that feeding fermented whey permeate resulted
in a lowered population of coliform bacteria in the gas-
trointestinal digesta of piglets postweaning challenged
with ETEC F4 [34] and Manurung [8] reported that feed-
ing whey permeate fermented with Weissella viridescens
reduced ETEC F4-induced PWD in piglets.
Table 4 Bioactive components in casein
Bioactive compounds Biological activities References
Anti-microbial peptides:
- as1-casein Isracidin from as1-casein exhibits antibiotic-type activity in vivo against
S. aureus and Candida albicans
[55, 126]
Isracidin protects mice against Candida albicans through stimulation of
both phagocytosis and immune responses
[126]
- as2-casein Casocidin-I from as2-casein has anti-bacterial properties against E. coli,
Staphylococcus spp., Sarcina spp., Bacillus subtilis, Diplococcus pneumoniae
and Streptococcus pyogenes in vitro
[55, 126, 127]
- b-casein Peptides from bovine b-casein (f193–209) enhance the anti-microbial activity of
mouse macrophages
[55]
- k-casein GMPs from k-casein reduce the adhesion of ETEC F4 to the intestinal
mucosa, increase the lactobacilli population in the intestine and reduce
the overgrowth of enterobacteria in the digestive tract of piglets after an
ETEC F4 challenge
[59]
Immunomodulating peptides:
- as1-casein Acts as a humoral immunostimulator in cell culture [128]
Phosphoserine-rich residues 59–79 from bovine as1-casein exhibit a mitogenic
activity and a stimulatory activity on Igs production
[48]
Peptides isolated from bovine as1-casein (f194–199 and f1–23)
increase the phagocytotic activity of human and murine macrophages
in vitro
[129]
- as2-casein Peptides isolated from bovine as2-casein (f1–32) enhance the proliferative
response induced by lipopolysaccharide (LPS), phytohaemagglutinin
(PHA) and concanavalin A (ConA) stimulation and the Igs production in
mouse spleen cell cultures
[55, 128]
- b-casein Peptides isolated from bovine b-casein (f63–68, f191–193, and f193–209)
increase the phagocytotic activity of human and murine macrophages
in vitro
[55]
Peptides (f1–28) enhance the proliferative response induced by LPS,
PHA and ConA stimulation and the Igs production in mouse spleen
cell cultures
[128]
- k-casein Increases proliferation of human peripheral blood lymphocytes in vivo [127]
GMPs derived from k-casein inhibit the proliferation of mouse splenocytes
in vitro
[48, 130]
GMPs derived from k-casein have immunomodulatory and bacterial
toxin-binding effects, and exert intestinal anti-inflammatory activity in the
trinitrobenzenesulfonic acid-induced model of colitis in rats
[56]
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Beyond the source of lactose, whey permeate contains
oligosaccharides with compositions similar to those pre-
sent in human milk [14]. These oligosaccharides have been
shown to exhibit prebiotic activity, and are therefore
essential for supporting the growth of LAB in the gut
of the host. In addition, oligosaccharides may act as
competitive inhibitors for the binding sites of pathogenic
E. coli on the epithelial surfaces of the intestine [10] and
they enhance the inflammatory immune responses against
invading pathogens [37]. These properties of oligo-
saccharides appear to be essential for the prevention
of ETEC colonization in the gut and consequently for the
development of ETEC-induced diarrhoea in piglets.
Preventive potential of casein on ETEC infections
in piglets
Casein is the major source of protein in bovine milk,
approximately 80% of the total milk protein fraction [54].
The physical properties of casein in the gut are quite
distinct from the properties of whey protein [44]. Because
of the low pH condition, micellar casein forms clots within
the stomach, which slows gastric emptying and their exit
from the stomach. This is in part responsible for the
previously mentioned lower absorption rate of casein in
its native micellar form compared with whey [44, 45].
Casein is formed by a-, b- and k-casein subunits, which
have been shown to possess several immunomodulatory
properties [31, 54]. Unlike whey, no specific anti-
microbial or immunomodulatory properties have been
proposed for the individual fractions of casein, but
various peptides are hidden in an active state inside the
polypeptide chain of casein [54, 55]. The polypeptide
chains of casein are broken down by enzymatic proteo-
lysis during in vitro as well as in vivo digestion, resulting
in biologically active peptides with anti-microbial and
immunomodulatory traits [40, 54]. Table 4 shows the
anti-microbial and immunomodulating peptides derived
from casein. Apart from the immunopotentiating effects
of casein-derived bioactive peptides, several immuno-
suppressive properties of k-casein may be of benefit
by regulating intestinal inflammation of the host and
counteracting excessive production of proinflammatory
cytokines [31]. López-Posadas et al. [56] reported that
k-casein-derived bovine glycomacropeptides (GMPs)
exert intestinal anti-inflammatory activity in the trinitro-
benzenesulfonic acid-induced model of colitis in rats,
which may be primarily related to actions on Th1 and
Th17 lymphocytes and macrophages. In addition, GMPs
appeared to preserve the intestinal epithelium of rats [56].
It has been apparent that amino acids are important for
the development and/or regulation of the host immune
responses. Compared with whey protein, casein contains
higher proportions of histidine, phenylalanine, valine,
arginine, glutamic acid, proline, serine and tyrosine [45]. In
addition, casein and whey differ in the nature of peptides
produced by in vitro and in vivo enzymatic proteolysis
[45, 54]. As certain amino acids and peptides may exert
specific immunomodulatory effects [45], treatments with
milk proteins have been speculated to affect the immune
regulation of the host. In our previous study, feeding
piglets with casein compared with whey resulted in a
higher concentration of total IgA in the intestinal mucosa
and a higher percentage of CD3+ T cells in the blood [9].
Because of its potential anti-microbial and immunomo-
dulatory capacities, interest has arisen in the use of casein
or biologically active peptides of casein as a means to
prevent diarrhoea. For example, b-casomorphins derived
from b-casein have been reported to modulate water and
electrolyte absorption and exert an anti-diarrhoeal action
in animals and in humans [57]. Accordingly, k-casein-
derived GMPs protect the mice against diarrhoea caused
by cholera toxins [58]. However, Hermes et al. [59]
reported that feeding casein-derived GMPs did not reduce
the incidence of PWD in piglets challenged with ETEC F4,
although the treatment reduced the adhesion of ETEC F4
to the intestinal mucosa. With regard to the whole casein,
de Mattos et al. [60] reported that a casein-based diet
did not interfere with the improvement and/or recovery
of patients with persistent diarrhoea. In a recent pig study,
inclusion of casein in the diet had no significant impact on
the development of PWD in piglets after challenged with
ETEC F4 [9]. So far, the data regarding the effect of casein
or casein-derived bioactive peptides on the development
of PWD in piglets is limited.
Preventive potential of fermented milk and related
products on ETEC infections in piglets
Fermented milk products have long been considered as an
important component in the human nutrition [61]. Yogurt
and kefir are examples of the fermented milk products
that have been consumed by human for centuries. Fer-
mented milk is prepared by fermenting the milk with LAB
(most commonly used), which is naturally found in milk or
which may be added to the milk. This fermentation makes
the products totally digestible and results in the release of
peptides and amino acids that are more easily utilized by
the host. In addition, the enzymatic activity of LAB in
fermentation may produce a variety of milk-derived bio-
logically active peptides with anti-bacterial and immuno-
modulatory properties [30, 62]. It should be noted that
the specific activity and amount of bioactive peptides in
fermented dairy products may depend on many factors,
including the chemical composition of the raw milk, the
type of bacterial starters used, the processing of the
product and the time of fermentation [30]. In addition
to a decreased content of potentially harmful bacteria,
fermentation generates a product with high content of
favourable bacteria such as LAB. This bacterial line plays,
in addition to the bioactive peptides released from
milk protein during fermentation, a significant role in
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determining the positive health effects of fermented milks
and related products [61].
In general, the beneficial effects of fermented dairy
products have been attributed to their ability to control
the growth of microbial pathogens in the gut as well as
to improve the intestinal immune functions of the host
[61, 63]. There have been several studies reporting the
benefits of fermented milk or related products on the
gastrointestinal health of humans and/or animals, as indi-
cated by the number of a specific bacterial population
in the gut. For example, fermented milk, prepared with
a starter culture Lactobacillus delbrueckii ssp. bulgaricus
and Streptococcus thermophilus and supplemented with
the probiotic strains Lactobacillus acidophilus NCFM and
Bifidobacterium lactis Bi-07 and the prebiotic isomalto-
oligosaccharide, resulted in an increased number of faecal
populations of lactobacilli and bifidobacteria and
a decreased number of enterobacilli and Clostridium
perfringens in the human subjects [63]. These authors
also reported that the numbers of lactobacilli and bi-
fidobacteria were significantly increased, whereas
enterobacilli were decreased in the mice administered
fermented milk when compared with the control group.
In another study by de LeBlanc et al. [64], the consump-
tion of probiotic-fermented milk either by the mother
during nursing or by the offspring after weaning increased
the number of bifidobacteria in the large intestine of mice,
and this was accompanied by a decrease of the enter-
obacteria population. In pigs, feeding fermented milk
prepared with Lactobacillus casei strain Shirota increased
the numbers of indigenous lactobacilli and bifidobacteria
in the intestine [65]. In addition, feeding fermented milk
increased faecal organic acid concentration and reduced
the faecal pH. In another study, Ohashi et al. [66]
reported that feeding yogurt, prepared with Lactobacillus
delbrueckii subsp. bulgaricus strain 2038, increased the
relative abundance of lactobacilli in the intestine of pigs.
The impact of fermented milk on the intestinal
microbiota of the host has been regarded to have a
positive consequence on the modulation of the gut
immune responses [64]. This condition, in concert with
the activities of the immunomodulatory peptides (pro-
duced during the fermentation), may therefore improve
host immunity. In the study of Wang et al. [63], adminis-
tration of fermented milk prepared with B. lactis Bi-07 and
L. acidophilus NCFM influenced the cellular and humoral
immunity of mice, apparently by increasing delayed-type
hypersensitivity (cell-mediated response), plaque-forming
cells and half-haemolysis values (closely associated with
humoral immunity). In addition, de LeBlanc et al. [64]
reported that treatment with fermented milk stimulated
the IgA+ cells, macrophages and dendritic cells in the
small intestine of mice, and thus improved the intestinal
mucosal immunity of the mice. In another study, oral
administration of milk fermentation products of Lacto-
bacillus helveticus R389 to mice increased total secretory
IgA in the intestinal lumen and enhanced the number of
IgA and various cytokine producing cells as well as the
secretion of interleukin (IL)-6 by small intestinal epithelial
cells [67]. The latter authors also revealed that the fer-
mented milk improved the intestinal mucosal immunity
by improving the mechanisms that reinforce epithelial
and non-specific barriers and the gut functioning at sites
of infection. More recent in vitro study by Zagato et al. [68]
reported that Lactobacillus paracasei CBA L74-fermented
milk had a strong anti-inflammatory activity on dendritic
cells in response to the inflammatory enteric pathogen,
Salmonella typhimurium, and hence may prevent inflam-
mation and tissue destruction.
Owing to the intestinal health benefits of fermented
milks, interest has arisen in the application of these pro-
ducts as means to prevent and/or treat the enteric
infections [61]. In the study of Guérin-Danan et al. [69],
provision of milk fermented with Lactobacillus casei
DN-114 001 significantly decreased the clinical signs of
rotavirus-associated diarrhoea, prevented rotavirus
infection in all sections of the intestine and reinforced
mucosa integrity of suckling rats. In another study,
treatment with milk fermented with L. helveticus R389 was
effective in prevention of Salmonella typhimurium infection
in mice [67]. Moreover, provision of L. paracasei CBA L74-
fermented milk protected infants against colitis or enteric
pathogens in vivo [68]. Unlike for human consumption,
fermented milk and related products for pigs are most
commonly prepared from the inexpensive by-products of
dairy industry such as whey or whey permeate. In general,
the application of these products to control the devel-
opment of ETEC-induced diarrhoea in piglets is still
scarce, and the results appear to be variable. As men-
tioned above, Manurung [8] showed benefits of fermented
whey permeate for reducing ETEC F4-PWD incidence.
However, Amezcua et al. [70] did not observe significant
positive effect of feeding fermented liquid whey (plus
dextrose) prepared with Lactobacillus plantarum on the
occurrence of ETEC F4-PWD, although less occurrences
of diarrhoea were actually observed in the piglets fed
fermented liquid whey than those of fed non-fermented
liquid whey.
In addition to the characteristics (e.g. chemical com-
position) of the raw milk or the milk by-product, studies
have revealed that the impacts of LAB on the health of
humans and/or animals are species or strain-specific [71].
The difference in species or strain of LAB used as a starter
inoculum during fermentation may in part be responsible
for the preventing potential of specific fermented milk
products or milk by-product on ETEC infections in pigs.
Conclusions
The removal of in-feed antibiotics from swine diets
has encouraged researchers to find antibiotic alternatives
that can control ETEC infections in piglets postweaning.
A number of nutritional strategies have been suggested to
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prevent ETEC infections in piglets. BC, milk and
milk fractions such as whey and casein contain several
bioactive components (e.g. whey protein, casein-derived
peptides, lactoferrin, lysozyme, lactoperoxidase, oligo-
saccharides, phospholipid and glycoconjugates) with anti-
microbial and immunomodulatory properties, and thus
possessing preventive effects on ETEC infections in piglets
postweaning. Likewise, fermented dairy by-products (e.g.
whey or whey permeate) appear to exert potentially
anti-infective properties against ETEC. The preventing
potential of dairy-based products on ETEC infections is
attributable to their capacity to improve the intestinal
barrier functions, the microbial ecology and the immunity
of piglets. To date, the application of dairy-based products
as anti-infective agents against ETEC infections in piglets
is still limited, and thus further research is needed to
elucidate the effectiveness of the products in preventing
ETEC infections in piglets. Hence, collaboration between
the dairy and the pig production industry is suggested to
utilize the preventing potentials of dairy-based nutrition
to increase the resilience of pigs toward pathogenic
infections and diseases.
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37. Miciński J, Zwierzchowski G, Kowalski IM, Szarek J.
Health-promoting properties of selected milk components.
Journal of Elementology 2013;18:165–86.
38. Przybylska J, Albera E, Kankofer M. Antioxidants in
bovine colostrum. Reproduction in Domestic Animals
2007;42:402–9.
39. Hurley WL, Theil PK. Perspectives on immunoglobulins in
colostrum and milk. Nutrients 2011;3:442–74.
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